Clinical evidence

Bactiguard's products have a substantial impact on the lives and health of human beings, therefore we conduct clinical studies on an ongoing basis in both Sweden and abroad, and in cooperation with physicians, nurses and other healthcare professionals. All our studies are designed according to international and local laws, regulations and ethical principles. They are reviewed and approved by ethical committees and relevant authorities.

Clinical studies

The purpose of the clinical studies is primarily to assess the technology efficacy of preventing infections, and its safety profile. The clinical evidence is substantial and shows that Bactiguard's infection protection technology prevents healthcare associated infections in an efficient and tissue-friendly way, without any toxic or pharmacological release.1

Over 180 million Bactiguard-coated products have been used in clinical care without any adverse events related to the coating have been reported.

References:
1. Data on file 
Clinical evidence